Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02868021
Other study ID # IRB201601042
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 12, 2016
Est. completion date August 1, 2018

Study information

Verified date July 2019
Source University of Florida
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot study will investigate the effects of blood flow restriction (BFR) exercise for up to 4-6 weeks prior to total knee arthroplasty (TKA) surgery in older patients to measure clinical outcomes such as strength, lower extremity function, and pain.


Description:

The purpose of this study is to test the feasibility and efficacy of a low-resistance exercise protocol with blood flow restriction (BFR) using a tourniquet in the preoperative period of patients awaiting TKA. BFR exercise is a new exercise method that has not been studied in the perioperative period. The investigators will compare our intervention to a no-exercise group up to 4 - 6 weeks prior to surgery to determine if this type of exercise is feasible in the preoperative period and if BFR exercise will improve functional, physiological, and molecular outcomes when compared to patients without exercise.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date August 1, 2018
Est. primary completion date August 1, 2018
Accepts healthy volunteers No
Gender All
Age group 55 Years to 80 Years
Eligibility Inclusion Criteria:

- are scheduled for elective TKA for osteoarthritis

- are scheduled for unilateral joint replacement surgery only

- are able to give consent and follow instructions

- are willing to complete up to 15 study visits

Exclusion Criteria:

- patients below the age of 55 years old

- patients over the age of 80 years old

- patients who live in a radius greater than 45 miles from the University of Florida (a feasible distance to allow for transportation to and from the clinical center for assessment visits)

- patients with impaired cognitive function and mental disease, (e.g. diagnosis of Alzheimer's disease)

- patients with paraplegia/extremity amputation

- patients with end stage renal disease requiring dialysis

- patients with uncontrolled diabetes and insulin-dependent diabetes

- patients with uncontrolled cardiovascular disease e.g. (Classes of Heart Failure (CHF) New York Heart Association (NYHA) class 3 or higher, BP > 180/110 mmHg)

- patients with severe pulmonary disease requiring continuous oxygen therapy

- patients with active neoplasm

- patients with peripheral vascular disease or deep vein thrombosis (within the last 3 years)

- patients with structured exercise/Physical Therapy(PT)/Occupational Therapy (OT)/fitness program enrollment within 12 weeks prior to surgery and/or more than 2 hours per month on gym/fitness room exercises

- patients with BMI greater than 40 kg/m2

- patients with opioid use of more than 30 mg Morphine-equivalents per day

- patients with chronic oral steroid use

- patients with chronic anticoagulation (e.g. Plavix, Warfarin)

- patients with planned postoperative admission to a skilled nursing/inpatient rehab facility

- patients with ipsilateral joint disease involving hip, ankle or spine

- neurologic or other etiology of quadriceps wasting

- surgery within less than 4 weeks

- patients with comorbidities that the PI judges as not suitable for the study

- patients with a minimal mental status (MMSE) score below 24

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Strength testing
Test the strength of subject's lower extremity muscles on the dynamometer system
Behavioral:
Short Physical Performance Battery (SPPB)
The SPPB is a timed short distance walk, repeated chair stands, and balance test that measures lower extremity function.
Six-minute walk (SMW)
Subjects walk back and forth along a 100-ft hallway for six minutes after instructions to complete as many laps as possible.
Numerical pain scale
Measure pain using an 11-point numerical pain scale.
Self-assessed function
Using the Late Life Function and Disability Instrument.
Procedure:
Muscle biopsies
During the course of the surgery two small muscle biopsies from the quadriceps muscle of the operative leg will be collected.
Device:
Determination of 1 Repetition Maximum (1-RM)
Following the warm-up, subjects will attempt to complete one repetition of the leg press exercise at progressively greater resistance until a full repetition can no longer be performed. The weight of the last complete unassisted repetition will be recorded as the 1-RM.
Blood flow restriction exercise
Perform lower-extremity exercises (leg press, leg extension, leg curl, and calf extension) at an intensity of 30% of 1-RM with external compression applied to the proximal thigh of each leg.
Behavioral:
Borg CR10 scale
Following each exercise session, participants will provide a rating of perceived exertion (RPE) for the session according to the Borg CR10 scale.

Locations

Country Name City State
United States United States, Florida UF Health Gainesville Florida

Sponsors (2)

Lead Sponsor Collaborator
University of Florida University of Florida Clinical and Translational Science Institute (CTSI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes between the two group assessed by muscle strength Test the strength of subject's lower extremity muscles on the dynamometer system Changes from baseline (pre-op) up to 2 weeks post-op
Secondary Changes between the two group assessed by Short Physical Performance Battery (SPPB) SPPB is a validated test to measure lower extremity function a timed short distance walk, repeated chair stands, and balance test. Changes from baseline (pre-op) up to 2 weeks post-op
Secondary Changes between the two group assessed by Six-minute walk (SMW) test SPPB is a validated test to measure lower extremity function a timed short distance walk, repeated chair stands, and balance test. Changes from baseline (pre-op) up to 2 weeks post-op
Secondary Changes between the two group assessed by pain Measure pain using an 11-point numerical pain scale Changes from baseline (pre-op) up to 2 weeks post-op
Secondary Changes between the two group assessed by self-assessment outcomes Assessed using the Late Life Function and Disability Instrument Changes from baseline (pre-op) up to 2 weeks post-op
Secondary Changes between the two group assessed by biological targets on the muscle tissue Analysis of the muscle tissue will focus on metabolism, inflammation, autophagy, apoptosis and other mechanisms of muscular atrophy. Up to 4 hours (end of surgery)
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Not yet recruiting NCT02865174 - Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty Phase 4
Completed NCT02881775 - Immediate Effects of rTMS on Excitability of the Quadriceps With Knee Osteoarthritis N/A
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4